Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Jones

Showing results (391-400 of 945) with videos related to

Pageof 95
Sort By:
Diagnostic Microbiology and Infectious Disease|November 21, 1998
Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection seasonR N Jones, M A Pfaller, G V Doern
Diagnostic Microbiology and Infectious Disease|July 1, 1992
The E-Test applied to susceptibility tests of gonococci, multiply-resistant enterococci, and Enterobacteriaceae producing potent beta-lactamasesM L Sanchez, M S Barrett, R N Jones
International Journal of Antimicrobial Agents|February 19, 2002
Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998-1999) including an in vitro evaluation of BMS284756J M Bell, J D Turnidge, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease|February 17, 1999
Antimicrobial activity of SCH27899 (Ziracin), a novel everninomicin derivative, tested against Streptococcus spp.: disk diffusion/etest method evaluations and quality control guidelines. The Quality Control Study GroupS A Marshall, R N Jones, M E Erwin
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 10, 2006
Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004)A C Gales, R N Jones, H S Sader
Journal of Chemotherapy (Florence, Italy)|January 15, 2010
Antimicrobial resistance among Gram-positive bacteria isolated in Latin American hospitalsH S Sader, G J Moet, R N Jones
The Journal of Antimicrobial Chemotherapy|January 1, 1994
In-vitro activity of FK-037, a new parenteral cephalosporinR N Jones, M S Barrett, M E Erwin
The Journal of Antimicrobial Chemotherapy|May 1, 1992
In-vitro activity of LY264826, an investigational glycopeptide antibiotic, against gram-positive bloodstream isolates and selected gram-negative bacilliT M Perl, R P Wenzel, R N Jones
Journal of Chemotherapy (Florence, Italy)|March 20, 2009
Emergence of a plasmid mediated bla (VIM-1) in Citrobacter koseri: report from the SENTRY Antimicrobial Surveillance Program (Italy)M Castanheira, E Debbia, A Marchese, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1994
Application of the Etest to antimicrobial susceptibility testing of Legionella sppP R Rhomberg, M J Bale, R N Jones
Pageof 95

Showing results (391-400 of 945) with videos related to

Sort By:
Pageof 95
Diagnostic Microbiology and Infectious Disease|November 21, 1998
Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection seasonR N Jones, M A Pfaller, G V Doern
Diagnostic Microbiology and Infectious Disease|July 1, 1992
The E-Test applied to susceptibility tests of gonococci, multiply-resistant enterococci, and Enterobacteriaceae producing potent beta-lactamasesM L Sanchez, M S Barrett, R N Jones
International Journal of Antimicrobial Agents|February 19, 2002
Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998-1999) including an in vitro evaluation of BMS284756J M Bell, J D Turnidge, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease|February 17, 1999
Antimicrobial activity of SCH27899 (Ziracin), a novel everninomicin derivative, tested against Streptococcus spp.: disk diffusion/etest method evaluations and quality control guidelines. The Quality Control Study GroupS A Marshall, R N Jones, M E Erwin
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 10, 2006
Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004)A C Gales, R N Jones, H S Sader
Journal of Chemotherapy (Florence, Italy)|January 15, 2010
Antimicrobial resistance among Gram-positive bacteria isolated in Latin American hospitalsH S Sader, G J Moet, R N Jones
The Journal of Antimicrobial Chemotherapy|January 1, 1994
In-vitro activity of FK-037, a new parenteral cephalosporinR N Jones, M S Barrett, M E Erwin
The Journal of Antimicrobial Chemotherapy|May 1, 1992
In-vitro activity of LY264826, an investigational glycopeptide antibiotic, against gram-positive bloodstream isolates and selected gram-negative bacilliT M Perl, R P Wenzel, R N Jones
Journal of Chemotherapy (Florence, Italy)|March 20, 2009
Emergence of a plasmid mediated bla (VIM-1) in Citrobacter koseri: report from the SENTRY Antimicrobial Surveillance Program (Italy)M Castanheira, E Debbia, A Marchese, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1994
Application of the Etest to antimicrobial susceptibility testing of Legionella sppP R Rhomberg, M J Bale, R N Jones
Pageof 95